What documentation a pain management practice should request
Before adding any biologics line to its supply chain, a pain management or physical medicine practice typically asks for three things: the certificate of analysis for the lot being ordered, a donor eligibility and screening summary, and a plain description of how the product was processed and tested. Precision Biologics makes this documentation available to verified accounts rather than publishing it broadly, since the relevant specifics vary by lot.
For exosome products specifically, practices should know that FDA has stated there are no FDA-approved exosome products and that these products are generally regulated as biologic drugs. Precision Biologics does not advise on clinical use, dosing, or procedures; that determination, and the regulatory review behind it, belongs to the practice and its own counsel.
Jackson
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
52- Pain Medicine
- 34
- Physical Medicine & Rehabilitation
- 18
Setting up an NPI-verified account
Account setup starts with the practice's NPI number, which Precision Biologics verifies before any order can be placed. A pain management group with several treating providers can register the group's NPI and list each ordering provider under one account, which keeps reordering simple while limiting purchasing authority to licensed professionals.
- Practice or group NPI number
- Name of the ordering provider
- Shipping and billing contact
- Products under evaluation
Receiving shipments in the Southeast
Cryopreserved products ship overnight on dry ice in containers validated to hold -80 C storage conditions through transit, while lyophilized products ship at ambient temperature without a cold chain requirement. A practice in Jackson receiving a cryopreserved order should plan for someone to receive and log the shipment promptly rather than let it sit unattended.
Lot numbers travel with each shipment so the practice can match what arrives against the certificate of analysis and keep its own patient-level traceability records separate from Precision Biologics' lot tracking.
How practices typically qualify a new vendor
Many pain management practices already have a vendor qualification checklist built for injectable or biologic products generally, and a Wharton's jelly or exosome supplier gets run through the same steps: documentation review, licensure verification, and a comparison of account terms against existing suppliers. Mississippi practices should also confirm their own compliance posture with the Mississippi medical board and independent counsel, since that review is specific to each practice's intended use.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Can a pain management practice in Jackson open an account with Precision Biologics?+
Yes, once the practice NPI is verified. Accounts are limited to licensed professionals and their practices.
Does the 52-provider figure for Jackson represent active biologics buyers?+
No. It is a count of 52 individual NPI-1 records with Pain Medicine or Physical Medicine & Rehabilitation as a primary taxonomy and a Jackson location, retrieved 2026-10-27. It says nothing about current purchasing activity.
What should a Jackson practice confirm before ordering an exosome product?+
That its intended use and regulatory posture have been reviewed with its own counsel, since FDA has stated there are no FDA-approved exosome products and treats them as biologic drugs.